Details of the Drug

General Information of Drug (ID: DMD8RU0)

Drug Name
SEphB4-HSA
Indication
Disease Entry ICD 11 Status REF
Kaposi sarcoma 2B57 Phase 2 [1]
Solid tumour/cancer 2A00-2F9Z Phase 1 [2]
Drug Type
Recombinant protein
Cross-matching ID
UNII
SO0RV2V6EJ
DrugBank ID
DB14797
TTD ID
DXWP72
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Ephrin type-B receptor 2 (EPHB2) TTKPV6O EPHB2_HUMAN Inhibitor [3]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 ClinicalTrials.gov (NCT03993106) A Study of sEphB4-HSA in Kaposi Sarcoma. U.S. National Institutes of Health.
2 ClinicalTrials.gov (NCT01642342) Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors. U.S. National Institutes of Health.
3 National Cancer Institute Drug Dictionary (drug name SEphB4-HSA).